申请人:Schmitz William D.
公开号:US20090018163A1
公开(公告)日:2009-01-15
The invention encompasses compounds of Formula I, including pharmaceutically acceptable salts, their pharmaceutical compositions, and their use in treating CNS disorders.
这项发明涵盖了Formula I的化合物,包括药用盐,它们的药物组合物,以及它们在治疗中枢神经系统疾病中的用途。